This study seeks to determine the feasibility, acceptability, and preliminary efficacy of an intervention consisting of off-label use of a medication with strong efficacy data for alcohol use disorder (AUD) with medical management and a clinical pharmacist-delivered behavioral intervention in reducing alcohol use among individuals with HIV and AUD.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Proportion of participants who complete enrollment and duration of sessions
Timeframe: 12 weeks
Number of sessions completed
Timeframe: 12 weeks
Adherence to Medication
Timeframe: 12 weeks
Safety of study assessed by adverse events reporting
Timeframe: 12 weeks